Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

A new study reveals benralizumab, an injectable drug, shows promise in reducing asthma and COPD flare-ups, outperforming traditional steroid treatments and minimizing side effects. The drug targets ...

The results demonstrate the safety and efficacy of Fasenra in the treatment of acute eosinophilic exacerbations in asthma and ...

The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an ...

The first new treatment for asthma attacks in 50 years has been hailed as a "game-changer" by doctors and patients.

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...

A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%.

The publication of this infographic was sponsored by ADVENT, a non-promotional medical education program designed to advance ...

The following is a summary of “Effect of Mepolizumab in airway’s remodelling in patients with late-onset severe asthma with ...

Editor’s note: Sarah Jones lives with a rare disease, eosinophilic granulomatosis with polyangiitis. She has more than 25 ...